Please set your featured image
appoints Head of Clinical Development
Oxford Pharmascience, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, today announces it has appointed Sheryl Caswell as Clinical Development Manager. Sheryl will be responsible for leading and executing the company’s clinical development strategy focused on the company’s two main medicines reformulation programmes in NSAIDs and Statins with reduced side effects. Sheryl will be a member of Oxford Pharmascience’s management team reporting to Marcelo Bravo, chief technology officer.
To read the article in full please see here